Mark Dixon
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Periodontics top 2%
- Oral microbiology and periodontitis research
Papers in
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Derry C. Roopenian (1 shared paper)Richard T. Evans (1 shared paper)Pamela J. Baker (1 shared paper)Michael J. Hallek (4 shared papers)Günter Fingerle‐Rowson (4 shared papers)Franck Morschhauser (3 shared papers)Richard Houghton (2 shared papers)John G. Gribben (2 shared papers)
- Journals
- Blood (9 papers)Infection and Immunity (1 paper)Hematological Oncology (1 paper)Diabetes Obesity and Metabolism (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United KingdomSwitzerlandGermany
In The Last Decade
Mark Dixon
17 papers receiving 1.4k citations
Mark Dixon's Hit Papers
Peers
Comparison fields: 5 of 39
- Genetics 686
- Periodontics 183
- Pathology and Forensic Medicine 122
- Oncology 47
- Hematology 28
Countries citing papers authored by Mark Dixon
This map shows the geographic impact of Mark Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dixon more than expected).
Fields of papers citing papers by Mark Dixon
This network shows the impact of papers produced by Mark Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dixon. The network helps show where Mark Dixon may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dixon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions Hit paper breakdown → | 2019 | 664 |
| 2 | 1999 | 291 | |
| 3 | 2017 | 105 | |
| 4 | 2017 | 104 | |
| 5 | 2015 | 76 | |
| 6 | 2020 | 48 | |
| 7 | 2016 | 24 | |
| 8 | 2015 | 23 | |
| 9 | 2024 | 16 | |
| 10 | 2015 | 12 | |
| 11 | 2014 | 10 | |
| 12 | 2014 | 9 | |
| 13 | 2016 | 9 | |
| 14 | 2022 | 5 | |
| 15 | 2016 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2023 | 1 |
About Mark Dixon
Mark Dixon is a scholar working on Genetics, Pathology and Forensic Medicine, Periodontics, Statistics and Probability and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (3 papers), Diabetes Treatment and Management (1 paper), Oral microbiology and periodontitis research (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Genetics (686 citations), Periodontics (183 citations), Pathology and Forensic Medicine (122 citations), Oncology (47 citations) and Hematology (28 citations). Mark Dixon has collaborated with scholars based in United Kingdom, Switzerland and Germany. Frequent co-authors include Derry C. Roopenian, Richard T. Evans, Pamela J. Baker, Michael J. Hallek, Günter Fingerle‐Rowson, Franck Morschhauser, Richard Houghton, John G. Gribben, Biljana Mihaljević and David A. Macdonald. Their work appears in journals such as Blood, Infection and Immunity, Hematological Oncology, Diabetes Obesity and Metabolism and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.